Actively Recruiting
The Benefits of Hippotherapy for Patients With Parkinson's Disease of 75 Years
Led by Central Hospital Saint Quentin · Updated on 2024-07-17
36
Participants Needed
1
Research Sites
52 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
There is no cure for Parkinson's disease, resulting in an interest for research in this domain. Non pharmacological measures remain essential, specifically physical activity. Hippotherapy is a nonconventional method which uses the horse in addition to standard care. The goal being to improve or maintain the gains of the person through cognitive, sensorial and motor stimulation, with the aim of improving quality of life and maintaining independence. With this in mind, the researchers propose to evaluate quality of life as the main criterion, using the PDQ8 scale validated for this disease. The researchers hope results will lead to the coverage of the costs of non-conventional therapies such as hippotherapy by social security services.
CONDITIONS
Official Title
The Benefits of Hippotherapy for Patients With Parkinson's Disease of 75 Years
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age 75 years or older with Parkinson's disease diagnosed by Movement Disorders Society criteria (2015)
- Clinical diagnosis of Alzheimer's disease
- On stable antiparkinsonian treatment for less than 3 months
- Ability to understand the study and its risks
- Written consent to participate
- Affiliated with social insurance
- Agree to follow all safety procedures during the study
- Ability to freely give informed consent
- Autonomy preserved
- Patient affiliated to social security or entitled beneficiary
You will not qualify if you...
- Younger than 75 years
- Refusal to sign consent
- MOCA score less than 23
- Major behavioral problems preventing optimal MRI
- Unable to receive informed information or participate fully
- Diagnosis of atypical parkinsonian syndromes
- Contraindications to MRI (e.g., claustrophobia, incompatible foreign material)
- History of high-level horse riding, animal phobias, or desire to stop study
- No affiliation to social security scheme
- Antiparkinsonian treatment not stable for at least 3 months
- Under protective supervision (guardianship, curatorship, or mandate for future protection)
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Centre Hospitalier de Saint-Quentin;
Saint-Quentin, Aisne, France, 02100
Actively Recruiting
Research Team
J
Jadwiga ATTIER, PHD
CONTACT
A
Abdelkrim BOULANOUAR, M
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
SUPPORTIVE_CARE
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here